HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and discussions with industry leaders, a consistent message emerged: healthcare artificial intelligence (AI) is entering a new phase of maturity. The focus has shifted beyond proof-of-concept initiatives toward enterprise-scale adoption, with organizations prioritizing governance, interoperability, workflow integration, and measurable business and clinical outcomes. Rather than questioning AI's potential, healthcare leaders are focused on deploying AI responsibly, embedding it into existing clinical and operational workflows, and demonstrating tangible value. This evolution reflects an important market inflection point, where success is increasingly determined not by AI capability alone, but by an organization's ability to operationalize AI at scale while maintaining trust, regulatory compliance, and human oversight. These observations formed the foundation of Frost & Sullivan's strategic imperatives, market themes, and growth opportunities presented in this report.

Author: Sagar Mukhekar